These findings suggested that TMEVPG1 might regulate the production of IFN-γ, the type II IFN which is presumed to contribute to distinct phenotypes of SS in addition to type I IFNs, by T-box expressed in T cells in the pathophysiology of SS [50]. The gene discussed is IFNG-AS1; the disease is synovial sarcoma.